Moors & Cabot’s CRISPR Therapeutics CRSP Stock Holding History

Moors & Cabot’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$265K	Buy
2024 Q2	–	Sell
2024 Q1	$202K	Sell
2023 Q4	$224K	Buy
2021 Q4	–	Sell
2021 Q3	$228K	Buy
2021 Q2	$305K	Buy
2021 Q1	$212K	Buy